Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Dexelvucitabine, a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.
Description | Dexelvucitabine, a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection. |
Synonyms | D-D-4FC, RVT, DPC-817, beta-D-D-4FC, DFC |
Molecular Weight | 227.19 |
Formula | C9H10FN3O3 |
CAS No. | 134379-77-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 30 mg/ml (132.05 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dexelvucitabine 134379-77-4 Microbiology/Virology Reverse Transcriptase D-D-4FC Inhibitor thymidine Human immunodeficiency virus d-d4FC cytidine M184V mutation antiretroviral inhibit Reverset 2′-deoxycytidine viral polymerase HIV resistant viruse nucleoside reverse transcriptase RVT DPC-817 HIV-1 beta-D-D-4FC DFC inhibitor